Genscript Biotech (HKG:1548) granted a total of 7,401,660 restricted shares to various participants under a 2019 restricted share award scheme, a Wednesday Hong Kong bourse filing said.
Of the total, 23,276 restricted shares were granted to executive director Li Zhu, 601,264 to rotating chief executive officer Weihui Shao, 6,707,292 to certain employees, and 69,828 to two individual consultants.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.